Sep 24 2021: We have confirmed the identification of the unid in this sample as Tibutylamine using a certified reference standard. Tributylamine is a leftover synthesis contaminant, probably a solvent that was accidentally left in the final product.
Sep 14 2021: Through DrugsData's expert network, we got a tentative identification of tributylamine for the unidentified substance in this sample. This may be a precursor chemical. A reference standard for tributylamine has been ordered, and the sample will be re-analyzed after the reference standard reaches the lab.
Sender code could be CLA25, CCA25, or LLA25 (first two characters are ambiguous).
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Sep 14 2021: Through DrugsData's expert network, we got a tentative identification of tributylamine for the unidentified substance in this sample. This may be a precursor chemical. A reference standard for tributylamine has been ordered, and the sample will be re-analyzed after the reference standard reaches the lab.
Sender code could be CLA25, CCA25, or LLA25 (first two characters are ambiguous).